CN Patent

CN102076362B — 尼古丁锭剂组合物

Assigned to GlaxoSmithKline LLC · Expires 2015-01-21 · 11y expired

What this patent protects

本发明涉及尼古丁锭剂组合物，其包括比传统的尼古丁锭剂低含量的缓冲剂，并且以更小型的、更方便的剂型提供了最佳口腔pH值和迅速的尼古丁吸收。

USPTO Abstract

本发明涉及尼古丁锭剂组合物，其包括比传统的尼古丁锭剂低含量的缓冲剂，并且以更小型的、更方便的剂型提供了最佳口腔pH值和迅速的尼古丁吸收。

Drugs covered by this patent

nicotine-polacrilex (NICOTINE POLACRILEX)

Patent Metadata

Patent number: CN102076362B
Jurisdiction: CN
Classification: —
Expires: 2015-01-21
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.